Generate a tailored SOP for Dr. Dong Sung. Improve your application with a focused, well-structured draft.
Dong Sung is a Professor and Associate Dean for Research Innovation at the UCLA School of Nursing, also affiliated with the UCLA AIDS Institute. His research focuses on the development of anti-HIV-1 gene therapies to address the significant health burden posed by HIV/AIDS, which has affected millions worldwide for over 40 years. Despite advancements such as highly active antiretroviral therapy (HAART), limitations persist in treating chronically infected individuals due to the existence of reservoirs that harbor the virus. Dr. Sung's team is exploring innovative approaches using genetic engineering techniques on human blood stem cells to create efficient gene delivery systems, aiming to impart long-lasting protection against HIV. His translational research seeks to bridge laboratory science with clinical practice to ultimately contribute to curing HIV. Research areas include HIV/AIDS and stem cell-based gene therapy, with an emphasis on strategies for treating HIV-infected patients through the introduction of protective genes into target cells.
Department of Economics admits primarily for the PhD program.